| Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ... The Journal of clinical investigation 126 (8), 3036-3052, 2016 | 631 | 2016 |
| Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma M Hegde, A Corder, KKH Chow, M Mukherjee, A Ashoori, Y Kew, ... Molecular Therapy 21 (11), 2087-2101, 2013 | 395 | 2013 |
| Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot study D Wild, M Fani, R Fischer, L Del Pozzo, F Kaul, S Krebs, JEF Rivier, ... Journal of nuclear medicine 55 (8), 1248-1252, 2014 | 232 | 2014 |
| Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study B Omer, S Krebs, H Omer, TO Noor Phytomedicine 14 (2-3), 87-95, 2007 | 169 | 2007 |
| Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn’s disease–a controlled clinical trial S Krebs, TN Omer, B Omer Phytomedicine 17 (5), 305-309, 2010 | 156 | 2010 |
| Characterization and functional analysis of scFv-based chimeric antigen receptors to redirect T cells to IL13Rα2-positive glioma G Krenciute, S Krebs, D Torres, MF Wu, H Liu, G Dotti, XN Li, MS Lesniak, ... Molecular Therapy 24 (2), 354-363, 2016 | 108 | 2016 |
| T cells redirected to interleukin-13Rα2 with interleukin-13 mutein–chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1 S Krebs, KKH Chow, Z Yi, T Rodriguez-Cruz, M Hegde, C Gerken, ... Cytotherapy 16 (8), 1121-1131, 2014 | 89 | 2014 |
| Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan D Reidy-Lagunes, N Pandit-Taskar, JA O'Donoghue, S Krebs, KD Staton, ... Clinical Cancer Research 25 (23), 6939-6947, 2019 | 83 | 2019 |
| Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors S Krebs, N Pandit-Taskar, D Reidy, BJ Beattie, SK Lyashchenko, ... European journal of nuclear medicine and molecular imaging 46, 677-685, 2019 | 52 | 2019 |
| IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron S Eskreis-Winkler, G Corrias, S Monti, J Zheng, M Capanu, S Krebs, ... Cancer Imaging 18, 1-7, 2018 | 44 | 2018 |
| Antibody with infinite affinity for in vivo tracking of genetically engineered lymphocytes S Krebs, A Ahad, LM Carter, J Eyquem, C Brand, M Bell, V Ponomarev, ... Journal of Nuclear Medicine 59 (12), 1894-1900, 2018 | 42 | 2018 |
| Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial S Krebs, B Omer, TN Omer, D Fliser American journal of kidney diseases 56 (6), 1095-1099, 2010 | 35 | 2010 |
| Pharmacokinetic assessment of 18F-(2S, 4R)-4-fluoroglutamine in patients with cancer M Grkovski, R Goel, S Krebs, KD Staton, JJ Harding, IK Mellinghoff, ... Journal of Nuclear Medicine 61 (3), 357-366, 2020 | 27 | 2020 |
| Genetically modified T cells to target glioblastoma S Krebs, TG Rodríguez-Cruz, C DeRenzo, S Gottschalk Frontiers in oncology 3, 322, 2013 | 27 | 2013 |
| Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic … S Krebs, JA O’Donoghue, E Biegel, BJ Beattie, D Reidy, SK Lyashchenko, ... European journal of nuclear medicine and molecular imaging 47, 3047-3057, 2020 | 23 | 2020 |
| Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ... The Journal of clinical investigation 129 (8), 3464-3464, 2019 | 22 | 2019 |
| Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment J Sponagel, JK Jones, C Frankfater, S Zhang, O Tung, K Cho, KL Tinkum, ... Med 3 (11), 792-811. e12, 2022 | 18 | 2022 |
| Imaging of CAR T-cells in cancer patients: paving the way to treatment monitoring and outcome prediction S Krebs, V Ponomarev, S Slovin, H Schöder Journal of Nuclear Medicine 60 (7), 879-881, 2019 | 17 | 2019 |
| MRI liver fat quantification in an oncologic population: the added value of complex chemical shift-encoded MRI G Corrias, S Krebs, S Eskreis-Winkler, D Ryan, J Zheng, M Capanu, ... Clinical imaging 52, 193-199, 2018 | 17 | 2018 |
| Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington’s disease: Consequences for cerebral transplantation programs SS Krebs, M Trippel, T Prokop, TN Omer, B Landwehrmeyer, WA Weber, ... Clinical and Experimental Neuroimmunology 2 (2), 25-32, 2011 | 17 | 2011 |
